proliferative diabetic retinopathy
Conditions
Interventions
Experimental group:vitrectomy surgery with 2 months oral Yuanqi Quyu Decoction
Control:vitrectomy surgery only
Sponsors
Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) a history of diabetes, B scan ocular ultrasound showed vitreous hemorrhage; (2) adults over the age 18 years; (3) vitrectomy did not cause significant damage to visual function, no complications such as choroidal hemorrhage, Traction retinal detachment of the retina successfully reset; (4) to use this treatment program adhere to treatment.
Exclusion criteria
Exclusion criteria: (1) suffering from retinal vein occlusion, retinal vein inflammation, ocular trauma, exudative age-related macular degeneration, Coat's disease and other diseases caused by vitreous hemorrhage; (2) with iris neovascularization, Neovascular glaucoma patients; (3) taking calcium dobesilate, difrarel; (4) had eye diseases due to intraocular surgery; (5) follow-up time of less than 6 months; (6) a history of drug abuse; (7) combined with severe heart, cerebrovascular, liver, kidney and hematopoietic system and other systemic diseases; (8) mental illness; (9) Be participating in other clinical drug trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visual acuity; | — |
Secondary
| Measure | Time frame |
|---|---|
| retina;glycosylated hemoglobin;postoperative complications; | — |
Countries
China
Contacts
Public ContactGao yunxian
Traditional`Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region
Outcome results
None listed